Bionic eye surgery to prompt medical tourism to Hawaii, doctor says

The Eye Surgery Center of Hawaii demonstrated the success of its first retinal bionic implant this week, which restored some vision to a patient with retinal blindness. “The patient has been training and going through rehabilitation and learning how to use it,” said Dr. Gregg Kokame of the Retina Consultants of Hawaii, who performed the Asia-Pacific region’s first implant of the Argus II artificial retina in March. “She was able to demonstrate that publicly for the first time… she was…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news

Related Links:

Authors: Reinehr S, Grotegut P, Tsai T, Wagner N, Joachim SC Abstract In view of the aging members of our society, there will be an increase in severe visual impairment and blindness, also due to glaucoma, in the coming years. Therapy options are limited to treat occurring symptoms. Currently, only a deceleration of the pathogenesis progression, but no cure, is available. Therefore, it is necessary to develop new therapeutic strategies to treat glaucoma adequately and effectively, thus improving the quality of life of those affected. One possible approach seems to be primary neuroprotection, which acts independentl...
Source: Klinische Monatsblatter fur Augenheilkunde - Category: Opthalmology Tags: Klin Monbl Augenheilkd Source Type: research
The prevalence of central nervous system (CNS) involvement in patients with acute myeloid leukemia (AML) is variable with a reported range of 0.6% to 46%. Unfortunately, the clinical consequences of untreated CNS involvement in AML which include complete paraplegia and bilateral total blindness, can be devastating. In addition, both the diagnostic evaluation and treatment of CNS involvement are associated with potential significant morbidity. Thus, there is a need to predict CNS involvement in a noninvasive manner in patients with AML.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Tags: 151 Source Type: research
Conclusion: There were no complications resulting from partial sternotomy in the two cases presented. CEA with partial sternotomy could be an effective treatment option for CCAO in which the internal carotid artery is patent and thrombus extends to the proximal CCA. PMID: 31966920 [PubMed]
Source: Surgical Neurology International - Category: Neurosurgery Tags: Surg Neurol Int Source Type: research
Cell Death &Disease, Published online: 24 January 2020; doi:10.1038/s41419-020-2255-0GCAP neuronal calcium sensor proteins mediate photoreceptor cell death in the rd3 mouse model of LCA12 congenital blindness by involving endoplasmic reticulum stress
Source: Cell death and disease - Category: Internal Medicine Authors: Source Type: research
It's the first treatment specifically approved for thyroid eye disease. The drug was approved Tuesday by the U.S. Food and Drug Administration. It will be marketed under the brand name Tepezza.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Contributors : Miae Oh ; Jiah YeomSeries Type : Expression profiling by arrayOrganism : Caenorhabditis elegansLipofuscin is known as intracellular waste substance produced by damaged mitochondrial incompleted decomposition. And it is a biomarker of aging. As aging, accumulation of the lipofuscin in retinal pigment epithelium induces blindness called Age-related macular degeneration. Soraprazan is developed to reduce the lipofuscin production and cure the age-related macular degeneration. Soraprazan reducing the age biomarker lipofuscin can be suggested to have effect of longevity extension. C.elegans were treated on NGM a...
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by array Caenorhabditis elegans Source Type: research
WEDNESDAY, Jan. 22, 2020 -- The newly approved drug teprotumumab can offer hope to adults with thyroid eye disease, a rare and potentially blinding condition. It's the first treatment specifically approved for thyroid eye disease. The drug was...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Our genome consists of 20,000 genes, all of which may be capable of triggering disease. It is estimated that there are 7,000 unknown genes that cause recessive genetic diseases resulting from mutations in two copies of a gene that have been inherited from each parent. Researchers at the University of Geneva (UNIGE), Switzerland, have recently identified 45 new genes that cause blindness or cognitive problems.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
[Vanguard] An Ophthalmologist, Dr. Adeniyi Irefin, says diabetes increases the risk of eye diseases like cataracts, glaucoma and diabetic retinopathy, which can lead to blindness if care is not taken.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
(IOS Press) Progress in research and technology is giving rise to an optimistic future for compensation and restoration of low vision, according to research in a special issue of Restorative Neurology and Neuroscience, published by IOS Press. Seven studies explore different aspects of vision loss after damage to the retina, optic nerve or brain due to diseases such as glaucoma or optic neuropathy. Remarkable progress is being made to treat conditions of partial blindness that have previously been considered irreversible.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Biotechnology | Blindness | Health | Health Management | Learning | Medical Tourism | Opthalmology | Rehabilitation | Training | Universities & Medical Training